ABOUT
Insight - Innovation - Access - Engagement - Partnering
The global partnering and investment summit for global leaders and innovators in CNS neuroscience and psychiatric drug discovery, development, platforms and technologies.
Convened by-invitation, Bio-Neuroscience is a high level, boutique gathering of key thought leaders, innovators and decision-makers from all key stakeholder groups crucial to the discovery, development and market launch of novel therapeutics and breakthrough platforms and technologies.
High level access, serious, sustained engagement, discussion and networking with key stakeholders. Sharing models, lessons learned, solutions, ways forward and best practices. A truly curated and unique summit to facilitate business and accelerate innovation.
ADVISORY BOARD
We are honored by the support of our Advisory Board.
Meet them in person at the summit.
 Stacie WeningerExecutive Director, F-Prime Biomedical Research Initiative |  David ReynoldsVenture Partner - SV Health Investors, CEO - LoQus23 Therapeutics |  Sourav KoleManaging Director - Dolby Family Ventures |  Joachim ScholppGlobal Head Translational Medicine CNS & Emerging Areas - Boehringer Ingelheim |
|---|---|---|---|
 Kalpana Merchant, PhDAdjunct Professor of Neurology, Northwestern University Feinberg School of Medicine Founder President & CSO, TransThera Consulting Co. |  Juan Carlos LopezManaging Director, Research Grants - RTW Charitable Foundation. Formerly Chief Editor - Nature Medicine & Founding Editor - Nature Reviews Neuroscience |  Mark TreherneCommercial Scientist, Entrepreneur & Investor. Chairperson - Monument Therapeutics, Talisman Therapeutics, Ubiqent, NuVision Biotherapies |  Pieter van BokhovenChief Scientific Officer - Amsterdam Neuroscience IAO - VUMC |
 Andrea Soto Padilla, M.D. PhDBusiness Development - Amsterdam UMC |  Pawel ŚwiebodaFounder - NeuroCentury; Practice Lead Neurotechnology, ICFG; Senior Advisor on Brain Health, FIPRA. |  Hakan GokerManaging Director, Head of Healthcare & Life Sciences - M-Ventures |  Christian J. SuojanenFounder & CEO - Broadreach Global, Member of the Board - European Brain Foundation |
SPEAKERS
Confirmed speakers include:
 Philip ScheltensHead of the Dementia Fund, Partner - EQT Life Sciences, Professor of Neurology - Amsterdam University Medical Center |  Martien KasPresident - European College of NeuroPsychopharmacology (ECNP), Professor of Behavioral Neuroscience - Groningen Institute for Evolutionary Life Sciences, University of Groningen |  Olga KrylovaDirector Of Business Development & Innovation - Otsuka Pharmaceutical Companies Europe |  José Luis LanciegoChair - International Brain Research Organization Pan-European Committee, Head, Laboratory of Functional Neuroanatomy of the Basal Ganglia, CNS Gene Therapy Program - CIMA, University of Navarra |
|---|---|---|---|
 Raúl Martín-RuizPartner - Ysios Capital |  Frédéric DestrebecqExecutive Director - European Brain Council |  Jason DichtenbergCEO – AccelBio, Executive Chairman – Evergreen Biosciences, Advisory Board Member – Alzheimers Drug Discovery Foundation, New York |  Thierry LaugelManaging Partner - Kurma Partners |
 Diana SaraceniCo-founder & General Partner - Panakes Partners |  Cillian KingManaging Director - EQT Life Sciences |  Christian ThomsenGlobal Head of CNS BD&L - Boehringer Ingelheim |  Carlos BuesaFounder & Chairman of the Board - Oryzon |
WHO'S COMING?
Two days of sustained, interactive discussion, networking and partnering with:
Industry Leaders
Senior industry leaders from pharma, large biotech and healthcare companies. Heads of therapeutic area, R&D, clinical development, biological sciences, M&A, scouting, business development & licensing.
Key Opinion Leaders
Key Opinion Leaders from all stakeholder groups crucial to the successful development, approval and market launch of novel CNS neuroscience and psychiatric therapeutics, platforms and technologies.
Founders & CEOs
From startup and growth companies at the cutting edge of the future of CNS neuroscience and psychiatric drug discovery, development, advanced therapies, platforms and technologies.
Government & NGOs
Public agencies, funding bodies, foundations, societies, associations, patient organizations & NGOs in CNS neurosciences and psychiatry.
Investors
In CNS neuroscience and psychiatric drug development, platforms and technologies.
VC and corporate venture, private equity, family offices, angels & HNW.
Leading Advisors
A selected group of leading specialized advisors and consultants with deep subject matter expertise relevant to participants.
PRESENTING COMPANIES
A curated selection of the best, world-class , innovative CNS neurosciences and psychiatric drug development companies with potential to transform healthcare, patient outcomes or markets. Selection is by excellence and potential, not by price tag.
There is no cost to present beyond the regular startup or private company registration fees.
Presenting Companies Receive:
- A 3 minute pitch plus 3 minutes of Q&A with an expert panel of relevant investors and industry: In the plenary session.
- Exclusive post presentation meeting space:
- Meeting Space: one of five reserved meeting spaces prominently placed next to the main networking area.
- 30 minutes in the networking break immediately following the presentation session.
- 2 Days of sustained engagement with the best network of innovators, investors, industry leaders & decision-makers in CNS neuroscience and psychiatric drug development and biopharma.
- Full access to the summit programme.
- Option to add an exclusive company exhibition stand.
VENUE
Rosarium
Amstelpark 1, Europaboulevard,
1083 HZ Amsterdam, Netherlands
Rosarium Amstelpark is one of the most presitigious meeting venues in Amsterdam, providing exceptional space for for plenary sessions, meetings and networking. With an open lobby area, wine bar, and adjacent Floriade gardens, it is a unique venue for a high level, by invitation summit like Bio-Neuroscience. Easily accessible by car (parking available), train, or boat.
CO-ORGANIZED BY
HOST PARTNER
ORGANIZING PARTNER
PARTNERS
GET IN TOUCH
Reach us here if you like to
-
Nominate a speaker
-
Apply to present your company or technology
-
Enquire about sponsorship & exhibition opportunities
Be the first to know
Subscribe and be among the first to receive all Broadreach Global updates, announcements and invitations.
Please make sure to double check your email address.
A Broadreach Global Initiative
Contact us at:
Follow us
